ASCO 2026: vídeos e entrevistas
90 vídeos do ASCO 2026 publicados por ASCO, ASCO Podcasts, ASH, OncLive, Oncology Brothers, Targeted Oncology e outros. Atualizado em 20/11/2026.
Immunotherapy updates in head and neck cancer from ASCO 2026VJOncology · 14/08/2026 · 18:35 · apoio da indústria
Updates in skin cancer from ASCO 2026VJOncology · 07/08/2026 · 16:51 · apoio da indústria
A Closer Look at Top ASCO 2026 Abstracts: Episode 4OncLive · 05/08/2026 · 5:04 · apoio da indústria
A Closer Look at Top ASCO 2026 Abstracts: Episode 3OncLive · 29/07/2026 · 3:41 · apoio da indústria
ASCO 2026: Highlights and analysisecancer · 27/07/2026 · 39:29 · apoio da indústria
A Closer Look at Top ASCO 2026 Abstracts: Episode 2OncLive · 22/07/2026 · 4:37 · apoio da indústria
GU cancer highlights from ASCO 2026VJOncology · 17/07/2026 · 16:48 · apoio da indústria
Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesoph...ecancer · 16/07/2026 · 5:48 · apoio da indústria
ASCO 2026: Breast cancer overviewecancer · 16/07/2026 · 4:58 · apoio da indústria
Bezuclastinib sunitinib combo shows promise in second-line GIST treatmentecancer · 16/07/2026 · 1:50 · apoio da indústria
Darolutamide shows less cognitive decline than enzalutamide in advanced prostate cancerecancer · 16/07/2026 · 4:35 · apoio da indústria
miR371 shows promise as a surveillance biomarker for relapse in early-stage germ cell tumoursecancer · 16/07/2026 · 4:28 · apoio da indústria
Aspirin use linked to improved survival in endometrial cancerecancer · 16/07/2026 · 3:07 · apoio da indústria
Mobile app-based symptom monitoring helps maintain quality of life in advanced cancerecancer · 16/07/2026 · 3:20 · apoio da indústria
Adjuvant avelumab reduces relapse risk in stage III Merkel cell carcinomaecancer · 16/07/2026 · 6:37 · apoio da indústria
GLP-1 therapy associated with reduced breast cancer risk in women with obesityecancer · 16/07/2026 · 4:05 · apoio da indústria
FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oro...ecancer · 16/07/2026 · 1:31 · apoio da indústria
A Closer Look at Top ASCO 2026 Abstracts: Episode 1OncLive · 15/07/2026 · 4:34 · apoio da indústria
Relacorilant chemo combination extends OS in platinum-resistant ovarian cancerecancer · 14/07/2026 · 3:28 · apoio da indústria
Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal...ecancer · 14/07/2026 · 5:36 · apoio da indústria
Gedatolisib combinations double PFS vs alpelisib in PIK3CA-mutant advanced breast cancerecancer · 14/07/2026 · 4:34 · apoio da indústria
ASCO 2026: Comment: Multi-cancer earlier detection testsecancer · 14/07/2026 · 4:42 · apoio da indústria
ASCO 2026: Lung cancer roundupecancer · 14/07/2026 · 4:04 · apoio da indústria
Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type metastatic colorectal cancerecancer · 14/07/2026 · 5:49 · apoio da indústria
Adjuvant selpercatinib reduces recurrence in RET-positive lung cancerecancer · 14/07/2026 · 2:11 · apoio da indústria
Abemaciclib shows benefit in dedifferentiated liposarcomaecancer · 14/07/2026 · 1:36 · apoio da indústria
Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancerecancer · 14/07/2026 · 3:47 · apoio da indústria
Omission of axillary lymph node dissection reduces arm morbidity without compromising survival i...ecancer · 08/07/2026 · 4:37 · apoio da indústria
Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancerecancer · 08/07/2026 · 3:53 · apoio da indústria
Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain m...ecancer · 08/07/2026 · 5:31 · apoio da indústria
ASCO 2026: Updates in testicular, germ cell and rare genitourinary cancerecancer · 08/07/2026 · 20:55 · apoio da indústria
ASCO 2026: Updates in renal cancerecancer · 08/07/2026 · 15:49 · apoio da indústria
ASCO 2026: Updates in bladder cancerecancer · 08/07/2026 · 21:27 · apoio da indústria
GI Malignancies Conference Highlights from #ASCO26 with Dr. Neena VijayvergiaOncology Brothers · 08/07/2026 · 2:05 · apoio da indústria
ASCO 2026 Breast Highlights: OPTIMA, lidERA, VIKTORIA-1, KEYNOTE-522, ASCENT-03/04, TROPION-Breast02Oncology Brothers · 02/07/2026 · 31:26 · apoio da indústria
RASOLUTE-302 (GI Conference Highlights) from #ASCO26 with Dr. Brian WolpinOncology Brothers · 01/07/2026 · 1:14 · apoio da indústria
Highlights in lung cancer from ASCO 2026: LIBRETTO-432, CROWN, and moreVJOncology · 26/06/2026 · 16:59 · apoio da indústria
GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPARTASCO Podcasts · 25/06/2026 · 30:29
Head & Neck Cancer and Sarcoma Conference Highlights from #ASCO26Oncology Brothers · 25/06/2026 · 1:49 · apoio da indústria
Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1ASCO Podcasts · 24/06/2026 · 13:28
ASCO 2026 GU Highlights & FDA Approvals with Drs. Brian Rini & Tom Powles (The Uromigos)Oncology Brothers · 22/06/2026 · 33:33 · apoio da indústria
Lung Cancer Conference Highlights from #ASCO26 with Dr. Isabel PreeshagulOncology Brothers · 21/06/2026 · 1:37 · apoio da indústria
Breast cancer highlights from ASCO 2026VJOncology · 19/06/2026 · 17:55 · apoio da indústria
Upper GI cancer highlights from ASCO 2026VJOncology · 17/06/2026 · 3:21 · apoio da indústria
ASCO 2026 highlights advances in targeted therapies for molecularly driven NSCLCVJOncology · 17/06/2026 · 6:47 · apoio da indústria
KRAS-Mutant Lung Cancer: ASCO 2026 Highlights & Emerging TherapiesTargeted Oncology · 16/06/2026 · 4:32 · apoio da indústria
Gastrointestinal cancer updates at ASCO 2026: RASolute 302, EMERALD-3, and moreVJOncology · 15/06/2026 · 16:01 · apoio da indústria
ASCO 2026 GI Highlights: EMERALD-3, FIGHT-302, CIRCULATE, MATTERHORNOncology Brothers · 15/06/2026 · 23:31 · apoio da indústria
ASCO 2026 Highlights: Breast & Lung Cancer Advances With Ajaz Khan, MDTargeted Oncology · 12/06/2026 · 3:41 · apoio da indústria
RASolute 302 Pancreatic Cancer Study with Daraxonrasib at ASCO 2026 – Dr. Brian WolpinOncology Brothers · 11/06/2026 · 22:49 · apoio da indústria
Key prostate cancer trials at ASCO 2026: PROTEUS, TALAPRO-3, and A-DREAMVJOncology · 10/06/2026 · 5:41 · apoio da indústria
Dr Hurvitz on Gedatolisib's Superior Efficacy in PIK3CA+ Breast CancerTargeted Oncology · 09/06/2026 · 5:45 · apoio da indústria
ASCO 2026: ADCs, KRAS Inhibitors & the Future of Breast Cancer Treatment with Dr TarantinoTargeted Oncology · 09/06/2026 · 2:35 · apoio da indústria
Breast cancer updates at ASCO 2026: KEYNOTE-522, SERENA-6, and moreVJOncology · 08/06/2026 · 1:50 · apoio da indústria
Highlights from ASCO 2026VJOncology · 08/06/2026 · 18:41 · apoio da indústria
ASCO 2026 Head & Neck AND Sarcoma Highlights – Drs. Samantha Armstrong & Ari RosenbergOncology Brothers · 08/06/2026 · 25:30 · apoio da indústria
Lung Cancer ASCO 2026 Highlights: LIBRETTO-432, CROWN Update, CHRYSALIS-2, HARMONi-6Oncology Brothers · 05/06/2026 · 22:01 · apoio da indústria
ASCO 2026: personalized vaccines and triplet immunotherapy in melanomaVJOncology · 04/06/2026 · 1:32 · apoio da indústria
Advances in TIL therapy for melanoma and solid tumors highlighted at ASCO 2026VJOncology · 04/06/2026 · 3:13 · apoio da indústria
Cell Therapy in Multiple Myeloma: Evolving Treatment Considerations For Relapsed/Refractory DiseaseOncology Brothers · 04/06/2026 · 26:36 · apoio da indústria